aspirin, 75 mg daily or more, for at least 2.8 years
DISEASE INTERVENTION COMPARISON RESULTS
Am J Med. 2012 Jun;125(6):560-7 Systematic Review
IN cancer, all types The Use of
aspirin, 75 mg daily or more, for at least 2.8 years
As Prevention, Primary
Is better Than
placebo
To reduce cancer deaths (2% aspirin VS 2.6% placebo) and noncardiovascular mortality (2.3% VS 2.6%)